Today’s AI Top Pick: ARRY

7/31/2026 · Highly Shorted Oversold screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Highly Shorted OversoldARRYBUY NOW7.8 / 107/31/2026

Array Technologies (ARRY) is the cleanest setup in this pool: it passes the screen (RSI 31.56, short float 20.39%) with genuine multi-timeframe forecast agreement AND a fresh positive catalyst that the tape hasn't fully priced in. Forecasts point up on every horizon that matters — 1h +57.7%, 4h short +42.8% / mid +62.9% / long +73.2%, 1d short +39.8% / mid +53.8% / long +51.3%, and the weekly mid/long is a monster at +64.3%/+103.8%. Bullish probability is 1.0 and near-term bullish is 1.0. Crucially, we are NOT chasing: daily position in the 21-bar range is only 14.9% with a -26.8% drawdown from the high, and the 4h position is 11.9%. That is a coiled spring, not an exhausted rally. The fundamentals corroborate: fwd P/E 5.59, PEG 0.36, P/S 0.65, sales YoY +13.2%, EPS next year +23.8%, operating margin positive (+4.34%), and analyst target upside +93.3% with recom 2.09. Fundamental score 2.5 is not the highest in the pool, but unlike TOYO (fund score 8 but forecasts turning negative and expected return −14.8%), ARRY's tape confirms the fundamentals. The 2026-07-30 Simply Wall St. note calling Atlas launch a catalyst that puts the undervalued narrative back in focus is exactly the kind of positive re-rating story you want when short interest is elevated and the chart is compressed. Why today, not later: RSI 25-32 across the pool is the entry window — waiting for confirmation means paying up. ARRY's 1h has already lifted to 91% of range on strong forecasts, meaning momentum has turned; the 4h/1d are still deeply oversold, giving you asymmetric entry. Weekly forecast short-term is only −1.7% (base-building), then explodes to +64%/+104% mid/long — this is the textbook pattern of a bottom being confirmed on higher timeframes. Earnings are the near-term risk (Q2 expected to decline per Zacks), but the setup already reflects that fear — the drawdown IS the earnings de-risking. Alternatives I passed on: PHAT (worst day in 1.5 years post-earnings — landmine), REPL (already +127% AH, chasing), KPTI (down 69% AH on Phase 3 miss — broken), TDOC (Q2 miss), MNRO (guidance concerns + PT cut today), FLO (first dividend cut in 24 years), ADTN (best fund score at 5.75 but weekly forecasts flat at −0.4/−0.13/+0.15 and two PT cuts), TOYO (best fund score but forecasts rolling over).

Entry zone

$5.05 - $5.20 (current $5.14, buy on any dip toward the 4h/1d lows without waiting for a breakout above $5.30)

Stop loss

$4.45 (below the weekly drawdown zone; ~13% risk, invalidates the base-building thesis)

First target

$6.50 - $6.80 (matches 4h short forecast of +42.8% and daily short-term move; also the pre-drawdown consolidation area)

Longer target

$8.50 - $10.50 (weekly long forecast +103.8% and daily long forecast +51.3%; analyst target upside +93.3% aligns)

Risks

Q2 earnings imminent with Zacks flagging expected EPS decline — a miss could drive another 15-20% downdraft before recovery
Debt/equity 2.85 and profit margin −10.61% mean any liquidity or rate shock hits hard; ROE −22.65%
Short float 20.39% cuts both ways — good for squeeze potential but shorts are informed on solar sector headwinds
Weekly short-term forecast is barely negative (−1.73%), meaning the immediate week could chop before the mid/long thesis plays out
Solar sector sentiment: RUN (peer) also oversold at RSI 25.8 and down 48% YTD — sector-wide de-rating is real

Honorable mentions

ABATDOE $57M grant reinstatement is a hard catalyst; 1h/4h/1d forecasts all +50-93%, RSI 31.42, but weekly forecasts weak (−9.9% mid) and profitability is disastrous (−390% margin). Higher-beta version of the trade.

RUNRSI 25.8 (deepest oversold), PE 4.45, ROE 19.13%, profit margin 17.94% — best actual profitability in the pool. 1h/4h/1d forecasts +13-52%, but earnings this week is a binary event and weekly short-term forecast is −2.91%.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	ARRY	BUY NOW	7.8	Multi-TF forecast alignment (1h/4h/1d/1wk all up mid/long), 15% of range, Atlas catalyst, fwdPe 5.59.
2	ABAT	BUY NOW	7.2	DOE grant reinstated, 1h+4h+1d forecasts +50-93%, target upside 218% — weekly is the wart.
3	RUN	BUY PULLBACK	7.0	Cheapest by PE (4.45), deepest RSI (25.8), but earnings this week — wait for the print.
4	ADTN	BUY PULLBACK	6.8	Best fundamental score (5.75) and RSI 23.21, but weekly forecasts are flat and two PT cuts last week.
5	LAC	BUY NOW	6.4	1h/4h forecasts +61-83%, 1d mid +59%, RSI 34.07, low debt, lithium narrative intact.
6	CRML	BUY PULLBACK	6.2	Massive forecasts (1h +88%, 4h +79%), target upside 237%, but 'overvalued after asset review' headline is a caution flag.
7	LUNR	BUY PULLBACK	6.0	1h forecast +159% is extreme; 4h +97% strong, but weekly turning down (mid -9.6%, long -32.8%).
8	SERV	BUY PULLBACK	5.9	Forecasts +71-108% on 1d/4h, RSI 34.92, but P/S 71 and −2643% profit margin — pure narrative.
9	MBRX	WAIT	5.5	Insane forecasts (weekly +726%) but $5.4M market cap penny stock; positive MIRACLE trial data is a real catalyst.
10	EVMN	BUY PULLBACK	5.3	1h/4h forecasts +104-116%, insider buying, but no weekly data and RSI 34.3 barely qualifies.
11	ACDC	BUY PULLBACK	5.2	1h forecast +116%, 4h/1d +40-53%, but recom 3.75 (analysts negative) and Q1 miss.
12	LFMD	BUY PULLBACK	5.0	1h/4h forecasts modest (+7-33%), weekly long +64.8%, but ROE −249% and PEG 6.59.
13	ACI	BUY PULLBACK	4.9	Insider $1.96M buy is bullish, 1d forecast +32-50%, but debt/equity 9.74 and PE 155.
14	VERA	WAIT	4.5	TRUTAKNA FDA approval real, but weekly forecasts negative (−9.6% mid, −21.7% long); earnings pending.
15	TOYO	AVOID	4.3	Best fundamentals (score 8, fwdPe 1.55, PEG 0.03) but daily and weekly forecasts negative — value trap.
16	MDCX	WAIT	4.0	FDA clearance for Gorlin trial is positive but $14.9M micro-cap with ROE −2336%.
17	NVAX	AVOID	3.8	Weekly forecasts −65 to −98%, sales YoY −52%, and short-term forecasts only +5-14%.
18	BIRD	AVOID	3.6	$20M micro-cap, ROE −153%, weekly forecast +14% mid but −38% long; M&A rumor only.
19	PHAT	AVOID	3.3	Worst day in 1.5 years post-Q2 — earnings landmine just detonated, wait for base.
20	FLO	AVOID	3.2	First dividend cut in 24 years, recom 3.14, and daily forecast only +13%.
21	MNRO	AVOID	3.1	Trading lower today on earnings, PT cut to $17, fwdPe 28.36.
22	METC	AVOID	2.9	Negative Q2 expectations, Goldman PT cut to $13, weekly forecast −6.7% short.
23	TDOC	AVOID	2.7	Q2 miss just hit, weekly mid +12% but 4h forecasts turning negative.
24	SNBR	AVOID	2.0	$2.88M market cap, down 98% YTD — the forecasts are numerical artifacts on a broken stock.
25	BTCT	AVOID	1.9	Private placement dilution, $5.3M cap, no forecast data useful.
26	PUMP	AVOID	1.8	Forecasts near zero to negative, bullish_prob 0, expected return −0.7%.
27	QCLS	AVOID	1.6	Weekly forecast −100% across all horizons, bullish_prob 0, terminated license agreement.
28	NRXP	AVOID	1.5	All 4h/1d/1wk forecasts negative, bullish_prob 0, recent dilution at $3.50.
29	KPTI	AVOID	1.2	Down 69% after-hours on Phase 3 XPORT-EC-042 failure — thesis destroyed.
30	REPL	AVOID	1.0	Already ripped 127% after hours; all forecasts strongly negative (−35 to −47%) — chasing after the move.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord